TAT and Adrenal insufficiency: Together, the present data illustrate the capacity for HIV-1 Tat to cause GR insensitivity (elevating basal circulating corticosterone levels) and promoting adrenal insufficiency in response to HPA activation to a natural or pharmacological challenge.